OKYO Pharma Ltd ADR
Quarterly Financials
| Values in thousands | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|
Gross Profit | -1 | -1 | -1 |
EBITDA | -3,751 | -1 | -1 |
EBIT | -3,752 | -2 | |
Net Income | -2,026 | -1 | -2,679 |
Free Cash Flow | -1,570 | -241 | |
Cash | 1,560 | 1,560 | 987 |
Basic Shares | 36,020 | 45 | 33,573 |
Annual Financials
| Values in thousands | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2 | -3 | -3 | -2 |
EBITDA | -7,083 | -15,745 | -13,183 | -6,215 |
EBIT | -7,086 | -15,749 | -13,186 | -6,217 |
Net Income | -4,706 | -16,825 | -13,272 | -5,431 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,812 | -9,490 | -7,701 | -5,469 |
Cash | 1,560 | 826 | 4,045 | 2,700 |
Basic Shares | 39,488 | 29,343 | 22,257 | 15,064 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.06 |
2024-12-31 | -$0.08 |
2024-06-30 | -$0.09 |
2023-12-31 | -$0.10 |
